Income StatementBalance SheetCash FlowSegments
AbbVie logo

AbbVie Business Segments

Business, geographic, and product segment breakdowns

AbbVie generates $62.8B in annual revenue across 4 key segments: All other ($2.9B), Botox Cosmetic ($2.7B), Botox Therapeutic ($3.9B), and Elahere ($709.0M). The company-wide operating margin is 24.41%. Based on the Q1 2026 filing.

All other (TTM)$2.9BBotox Cosmetic (TTM)$2.7BBotox Therapeutic (TTM)$3.9BElahere (TTM)$709.0MEpkinly (TTM)$303.0MHumira (TTM)$4.1BImbruvica (TTM)$2.7BJuvederm Collection (TTM)$994.0M
Latest FilingQ1 2026
Report Date2026-05-08
Market Cap$381.10B
P/E Ratio104.84
ROE-139.97%

Products & Services

Net revenues

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Skyrizi$3.8B$3.4B$4.4B$4.7B$5.0B$4.5B
Rinvoq$1.8B$1.7B$2.0B$2.2B$2.4B$2.1B
All other$752.0M$1.3B$603.0M$660.0M$617.0M$1.0B
Botox Therapeutic$873.0M$866.0M$928.0M$985.0M$990.0M$1.0B
Vraylar$924.0M$765.0M$900.0M$934.0M$1.0B$905.0M
Venclexta$655.0M$665.0M$691.0M$726.0M$710.0M$770.0M
Humira$1.7B$1.1B$1.2B$993.0M$1.2B$688.0M
Botox Cosmetic$687.0M$556.0M$692.0M$637.0M$717.0M$668.0M
Imbruvica$848.0M$738.0M$754.0M$706.0M$671.0M$556.0M
Mavyret$291.0M$306.0M$375.0M$312.0M$324.0M$351.0M
Ubrelvy$303.0M$240.0M$338.0M$354.0M$339.0M$339.0M
Qulipta$201.0M$193.0M$267.0M$288.0M$288.0M$296.0M
Other Aesthetics$332.0M$315.0M$327.0M$303.0M$320.0M$286.0M
Linzess$233.0M$148.0M$258.0M$326.0M$175.0M$283.0M
Juvederm Collection$279.0M$231.0M$260.0M$253.0M$249.0M$232.0M
Vyalev$44.0M$63.0M$98.0M$138.0M$183.0M$201.0M
Elahere$148.0M$179.0M$159.0M$170.0M$182.0M$198.0M
Other Neuroscience$56.0M$155.0M$55.0M$46.0M$47.0M$125.0M
Epkinly$40.0M$51.0M$70.0M$69.0M$81.0M$83.0M

Geographic

Net revenues

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other Countries$1.4B$1.4B$1.4B$1.4B$1.4B—

Total long-lived assets

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
All Other Countries$318.0M———$420.0M—
Europe$1.5B———$1.8B—
United States And Puerto Rico$3.3B———$3.4B—

Collaboration revenues

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
International—$209.0M$211.0M$199.0M—$224.0M